Publication | Closed Access

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

Breast OncologyMedicineClinical TrialsAdjuvant DenosumabDisease-free Survival ResultsBreast CancerMenopause Hormone TherapyCancer TreatmentOncologyRadiation OncologyPostmenopausal PatientsHealth Sciences